KPTI Annual Accounts Payable
$3.12 M
+$350.00 K+12.62%
31 December 2023
Summary:
As of January 22, 2025, KPTI annual accounts payable is $3.12 million, with the most recent change of +$350.00 thousand (+12.62%) on December 31, 2023. During the last 3 years, it has fallen by -$1.33 million (-29.82%). KPTI annual accounts payable is now -50.33% below its all-time high of $6.29 million, reached on December 31, 2014.KPTI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KPTI Quarterly Accounts Payable
$5.78 M
+$2.99 M+106.76%
30 September 2024
Summary:
As of January 22, 2025, KPTI quarterly accounts payable is $5.78 million, with the most recent change of +$2.99 million (+106.76%) on September 30, 2024. Over the past year, it has increased by +$2.99 million (+106.76%). KPTI quarterly accounts payable is now -36.06% below its all-time high of $9.04 million, reached on March 31, 2023.KPTI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KPTI Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.6% | +106.8% |
| 3 y3 years | -29.8% | +556.4% |
| 5 y5 years | -27.9% | +88.5% |
KPTI Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +94.8% | -36.1% | +611.3% |
| 5 y | 5-year | -29.8% | +217.1% | -36.1% | +611.3% |
| alltime | all time | -50.3% | +217.1% | -36.1% | +611.3% |
Karyopharm Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.78 M(+106.8%) |
| June 2024 | - | $2.80 M(-44.4%) |
| Mar 2024 | - | $5.03 M(+61.0%) |
| Dec 2023 | $3.12 M(+12.6%) | $3.12 M(+231.2%) |
| Sept 2023 | - | $943.00 K(-58.8%) |
| June 2023 | - | $2.29 M(-74.7%) |
| Mar 2023 | - | $9.04 M(+226.2%) |
| Dec 2022 | $2.77 M(+73.0%) | $2.77 M(+241.1%) |
| Sept 2022 | - | $813.00 K(-52.0%) |
| June 2022 | - | $1.69 M(-50.8%) |
| Mar 2022 | - | $3.44 M(+114.6%) |
| Dec 2021 | $1.60 M(-64.0%) | $1.60 M(+82.0%) |
| Sept 2021 | - | $881.00 K(-61.8%) |
| June 2021 | - | $2.31 M(-24.0%) |
| Mar 2021 | - | $3.04 M(-31.7%) |
| Dec 2020 | $4.45 M(+351.8%) | $4.45 M(+83.7%) |
| Sept 2020 | - | $2.42 M(+28.3%) |
| June 2020 | - | $1.89 M(+11.5%) |
| Mar 2020 | - | $1.69 M(+72.0%) |
| Dec 2019 | $985.00 K(-77.3%) | $985.00 K(-67.9%) |
| Sept 2019 | - | $3.07 M(+175.7%) |
| June 2019 | - | $1.11 M(-50.9%) |
| Mar 2019 | - | $2.27 M(-47.7%) |
| Dec 2018 | $4.33 M | $4.33 M(+93.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $2.24 M(-41.0%) |
| June 2018 | - | $3.79 M(-23.3%) |
| Mar 2018 | - | $4.95 M(-12.6%) |
| Dec 2017 | $5.67 M(+19.2%) | $5.67 M(+199.7%) |
| Sept 2017 | - | $1.89 M(-41.8%) |
| June 2017 | - | $3.25 M(-23.5%) |
| Mar 2017 | - | $4.25 M(-10.7%) |
| Dec 2016 | $4.75 M(+24.8%) | $4.75 M(+116.6%) |
| Sept 2016 | - | $2.19 M(-46.0%) |
| June 2016 | - | $4.06 M(-1.1%) |
| Mar 2016 | - | $4.11 M(+7.9%) |
| Dec 2015 | $3.81 M(-39.4%) | $3.81 M(-16.6%) |
| Sept 2015 | - | $4.57 M(+2.2%) |
| June 2015 | - | $4.47 M(-35.8%) |
| Mar 2015 | - | $6.96 M(+10.6%) |
| Dec 2014 | $6.29 M(+261.4%) | $6.29 M(+199.1%) |
| Sept 2014 | - | $2.10 M(-39.2%) |
| June 2014 | - | $3.46 M(+5.6%) |
| Mar 2014 | - | $3.27 M(+88.1%) |
| Dec 2013 | $1.74 M(+61.7%) | $1.74 M(-0.5%) |
| Sept 2013 | - | $1.75 M(+1.2%) |
| June 2013 | - | $1.73 M(+60.6%) |
| Dec 2012 | $1.08 M(-5.8%) | $1.08 M |
| Dec 2011 | $1.14 M | - |
FAQ
- What is Karyopharm Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual accounts payable year-on-year change?
- What is Karyopharm Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly accounts payable year-on-year change?
What is Karyopharm Therapeutics annual accounts payable?
The current annual accounts payable of KPTI is $3.12 M
What is the all time high annual accounts payable for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual accounts payable is $6.29 M
What is Karyopharm Therapeutics annual accounts payable year-on-year change?
Over the past year, KPTI annual accounts payable has changed by +$350.00 K (+12.62%)
What is Karyopharm Therapeutics quarterly accounts payable?
The current quarterly accounts payable of KPTI is $5.78 M
What is the all time high quarterly accounts payable for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly accounts payable is $9.04 M
What is Karyopharm Therapeutics quarterly accounts payable year-on-year change?
Over the past year, KPTI quarterly accounts payable has changed by +$2.99 M (+106.76%)